Zerto Announces Partner of the Year Awards for 2022
AHEAD and TierPoint recognized for their significant achievements BOSTON–(BUSINESS WIRE)–Zerto, a Hewlett Packard Enterprise company,…
AHEAD and TierPoint recognized for their significant achievements BOSTON–(BUSINESS WIRE)–Zerto, a Hewlett Packard Enterprise company,…
The Factual’s News Rating Technology Powers Transparency and Identifies Media Bias and Credibility in News…
More than 20 founders of companies like Snyk, Sumo Logic, Fastly, LaunchDarkly, GitHub, and Datadog…
12.8 Tb/s Flow Anomaly Detection, No-Compromise Network Security, Connected by Broadcom SAN JOSE, Calif., Sept….
MENLO PARK, Calif., Sept. 06, 2022 (GLOBE NEWSWIRE) — CohBar, Inc. (NASDAQ: CWBR), a clinical…
SAN CARLOS, Calif., Sept. 06, 2022 (GLOBE NEWSWIRE) — Iovance Biotherapeutics, Inc. (NASDAQ: IOVA), a…
FARMINGTON HILLS, Mich., Sept. 06, 2022 (GLOBE NEWSWIRE) — Ocuphire Pharma, Inc. (Nasdaq: OCUP), a…
BERLIN, Sept. 06, 2022 (GLOBE NEWSWIRE) — Tilray Brands, Inc. (“Tilray” or the “Company”) (Nasdaq:…
IRVINE, Calif., Sept. 06, 2022 (GLOBE NEWSWIRE) — Reneo Pharmaceuticals, Inc. (NASDAQ: RPHM), a clinical…
CAMBRIDGE, Mass., Sept. 06, 2022 (GLOBE NEWSWIRE) — Vericel Corporation (NASDAQ:VCEL), a leader in advanced…
BOSTON, Sept. 06, 2022 (GLOBE NEWSWIRE) — Galecto, Inc. (NASDAQ: GLTO), a clinical stage biotechnology…
MIAMI, Sept. 06, 2022 (GLOBE NEWSWIRE) — Veru Inc. (NASDAQ: VERU), a biopharmaceutical company focused…
PRINCETON, N.J., Sept. 06, 2022 (GLOBE NEWSWIRE) — Agile Therapeutics, Inc. (Nasdaq: AGRX), a women’s healthcare…
ANAHEIM, CA, Sept. 06, 2022 (GLOBE NEWSWIRE) — via NewMediaWire – BioCorRx Inc. (OTCQB: BICX)…
SAN DIEGO and REDWOOD CITY, Calif., Sept. 06, 2022 (GLOBE NEWSWIRE) — eFFECTOR Therapeutics, Inc….
CUPERTINO, Calif., Sept. 06, 2022 (GLOBE NEWSWIRE) — Reviva Pharmaceuticals Holdings, Inc. (NASDAQ: RVPH) (“Reviva”…
MIAMI, Sept. 06, 2022 (GLOBE NEWSWIRE) — Longeveron Inc. (NASDAQ: LGVN) (“Longeveron” or “Company”), a…
Alignment with the FDA on a regulatory path forward for the continued development of tebipenem…
NEWARK, Calif., Sept. 06, 2022 (GLOBE NEWSWIRE) — CymaBay Therapeutics, Inc. (NASDAQ: CBAY), a clinical-stage…
South San Francisco, Calif., Sept. 06, 2022 (GLOBE NEWSWIRE) — Satsuma Pharmaceuticals, Inc. (Nasdaq: STSA),…